z-logo
open-access-imgOpen Access
Pathogenetic background of dipeptidyl peptidase-4 inhibitors application in the management of diabetes mellitus type 2
Author(s) -
T. Yu. Demidova,
S.G. Kulenok,
P.A. Gasanzade
Publication year - 2017
Publication title -
consilium medicum
Language(s) - English
Resource type - Journals
eISSN - 2542-2170
pISSN - 2075-1753
DOI - 10.26442/2075-1753_19.4.23-28
Subject(s) - dipeptidyl peptidase 4 , type 2 diabetes mellitus , dipeptidyl peptidase , diabetes mellitus , medicine , dipeptidyl peptidase 4 inhibitor , type 2 diabetes , endocrinology , pharmacology , enzyme , chemistry , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom